The Big Picture: Why We NEED Local Pharma Power
Let’s cut to the chase: Nigeria needs to shake off its heavy dependence on foreign medicines. Kingsley Aguoru, the Managing Director of Colexa Bisensor Ltd, recently sat down with ARISE NEWS and laid it all out. He pointed out that despite years of talk and various government initiatives, our pharmaceutical sector is still importing a whopping 70% of what we need. That’s a huge chunk of our health budget going overseas when it could be fueling local growth and jobs right here at home.
Think about it: manufacturing is the backbone of any strong economy. It creates skilled jobs, builds up our technical know-how, and makes us more self-sufficient. Aguoru is pushing for a dramatic shift – a target of 70% local manufacturing and only 30% imports. This isn’t just a dream; it’s a necessary goal for national development.
Policy Flip-Flops: The Biggest Roadblock
Here’s a major frustration Aguoru highlighted: Nigeria’s policies can be like a weather vane, changing direction too often. He puts it bluntly: “You make a policy today, tomorrow you change it.” This inconsistency is a killer for businesses. Investors need to know that the rules won’t change on a whim. They need a stable environment to commit their resources to long-term projects like building factories and developing new drugs.
The bottom line? We need political will. Real, sustained commitment from the government to back local manufacturers. Without it, all the talk about reform and boosting local content remains just that – talk.
The Hurdles Local Manufacturers Face
It’s not easy being a local pharmaceutical manufacturer in Nigeria. Aguoru outlined several significant challenges:
- Costly Financing: Nigerian manufacturers often struggle with exorbitant commercial loan interest rates, sometimes as high as 30%, making it incredibly hard to compete with international companies that access capital at much lower rates.
- Power Problems: Inconsistent and unreliable electricity supply adds significant operational costs, as businesses have to invest heavily in alternative power sources.
- Tech Transfer Issues: Getting access to the latest manufacturing technologies can be a hurdle, limiting efficiency and product quality.
- Market Domination: Imported products often flood the market, making it tough for local players to gain market share, even when their products are of good quality.
- Underutilized Capacity: Many local factories are running way below their potential simply because there isn’t enough demand for their products, largely due to the preference for imports and market access issues.
Good News & Glitches: Colexa Biensor’s Success Story (and its lessons)
Amidst these challenges, there are success stories. Colexa Biensor Ltd’s move to start producing diagnostic test kits locally is a fantastic example of backward integration. Aguoru mentioned that this wasn’t a smooth ride; they faced resistance and numerous obstacles. But they pushed through! This shows that local production is possible, but it highlights just how tough the journey can be without strong, consistent support.
Government Procurement: A Double-Edged Sword
Government procurement policies that favour local products are a step in the right direction. However, Aguoru pointed out a critical flaw: these policies are often undermined by delayed payments. He put it perfectly: “It’s one thing to give me the business; it’s another thing to pay me for it.” This cash flow problem can cripple even the most promising local businesses.
Changing Perceptions and Looking Ahead
We also can’t ignore the public perception issue. For years, there’s been a lingering preference for imported goods, often seen as a mark of quality. Local manufacturers have to work twice as hard to prove their worth through rigorous quality assurance and consistent engagement with consumers. It’s a battle for trust.
Looking forward, Aguoru’s call to action is clear: the government needs to ensure that incentives truly benefit local producers, not importers. Waivers and grants should be structured to genuinely support those they are intended for. Consistent enforcement across all levels of implementation is key. If Nigeria is serious about strengthening its healthcare system and boosting its economy, it must commit to robust, unwavering support for its local pharmaceutical manufacturing sector. It’s time to stop talking and start doing!
Key Takeaways:
- Nigeria imports about 70% of its pharmaceutical products, a situation needing urgent change.
- Consistent government policies and long-term commitment are crucial for attracting investment and enabling local manufacturing.
- Local manufacturers face significant hurdles, including high financing costs, unreliable power, and stiff competition from imports.
- Successful local production requires not just good policies, but also timely payments and a shift in public perception towards valuing local products.
About The Author
